5-Lipoxygenase: a rational target for therapy of inflammatory bowel disease?
Wallace
J L
JL
Gastrointestinal Research Group, University of Calgary, Alberta, Canada.
D000818:Animals; D001091:Arachidonate Lipoxygenases / Q000037:antagonists & inhibitors*; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy* / Q000201:enzymology; D016859:Lipoxygenase Inhibitors
D016859:Lipoxygenase Inhibitors; D001091:Arachidonate Lipoxygenases